MTIP is the largest Pan-European growth equity investor purely focused on the healthtech sector, supporting companies that revolutionize global healthcare whilst generating top quartile returns to our investors. We invest in the most innovative healthtech companies that bring efficiency on healthcare accessibility, affordability, availability as well as quality. Our purpose is to empower innovation that improves lives by accelerating the adoption of digital technologies in healthcare.
We do this across digital health products, tech-enabled healthcare services as well as connected medical devices. As a leading impact investor, we actively engage with our companies on ESG topics, and believe social responsibility is critical for long-term and sustainable value creation. Thus, we are proud to be SFDR Art.9 compliant as of MTIP Fund II characterized as one of the first “dark green“ funds with our products targeting sustainable investments.
Largest and most experienced European Healthtech Growth Equity Investor: We contribute to a more sustainable and equitable world through our investments and actions.
As an impact investor, we are proud of our strong commitment to social responsibility that supports long-term and sustainable value creation providing capital to tackle inequality in access to quality healthcare.
We have developed a strong deal flow across all our core markets and have gained access to the most attractive healthtech investments.
Our deep specialization in healthtech creates a strong network effect across investment cycle.
We have a unique skill set within our investment team, consisting of specialists in healthcare, finance and software.
We create value through the team’s unique combination of sector and operational expertise for a successful exit.
We have a global network of sophisticated financial and strategic partners and advisors at our disposal.
As an impact-driven investor with social investment objective, our portfolio companies contribute to the achievement of Sustainable Development Goals.
We focus primarily on Europe including Switzerland, UK and Israel.
As healthtech investors, we cover digital health, tech-enabled healthcare services and connected medical devices.
We target equity investment of up to €50m per company throughout all financing rounds and minimum €10m as an initial investment.
We act as lead investors (selectively co-lead) and we seek to own significant minority equity stake in the businesses we invest in. As an active investor, we typically take a board position and engage with the executive team as “sparring partners“, advisors and a sounding board to accelerate growth.
We target growth stage companies with EUR 5m+ revenues and proven product-market fit with clear pathway to profitability (or profitable) during our investment period.
We invest in businesses with B2B characteristics, recurring or re-occurring revenue streams and scalable business models with significant growth opportunities within the investment period and clear focus on long-term value creation.
We hold investments 3-7 years and exit through sale to strategic, investor or IPO.
TrailBlazer is transforming MTIP’s investment decision-making process by utilizing cutting-edge AI technology, providing MTIP with a competitive advantage and a fresh approach to digital thinking.
Led by MTIP’s data science team, TrailBlazer started in 2021 with its mission to refine MTIP’s differentiated growth investment approach. TrailBlazer is an AI-powered prediction model that provides unique investing insights and a multidimensional, holistic company performance assessment. The platform is built on continuously growing data sources and can be used to identify the most promising investments for successful growth and value creation while mitigating risks.
TrailBlazer can improve the investment decision-making process and mitigate risk in several ways:
Data Analysis: TrailBlazer analyzes data from various sources to identify trends, providing deeper insights for informed decisions by the MTIP team
Predictive Modeling: AI models can use historical data to forecast future market trends. Through predictive modeling, we identify companies that are on a promising trajectory towards rapid growth
Portfolio Management & Monitoring: Our AI-powered model helps optimize the performance of our portfolio companies by analyzing operational data and identifying areas where efficiencies can be improved
Risk Management: Before MTIP takes an investment decision, TrailBlazer helps identify and analyze associated risks
Benchmarking Capabilities: Valuable insights into investment performance enable MTIP to benchmark capabilities for informed investment decisions